HISTIOCYTIC NEOPLASMS
Clinical trials for HISTIOCYTIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HISTIOCYTIC NEOPLASMS trials appear
Sign up with your email to follow new studies for HISTIOCYTIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets rare blood cancers in adults and teens
Disease control Recruiting nowThis study is testing whether the drug ulixertinib can safely control rare blood cancers called histiocytic neoplasms. Researchers will enroll 38 patients aged 12 and older whose cancer has continued to grow despite previous treatments. The trial focuses on patients whose cancers…
Matched conditions: HISTIOCYTIC NEOPLASMS
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New scan seeks to illuminate hidden cancers
Knowledge-focused Recruiting nowThis study is testing a new imaging agent used with PET/CT scans to see if it can better detect and measure certain blood cancers and rare tumors. It involves about 30 adult patients with conditions like non-Hodgkin lymphoma, multiple myeloma, or specific rare diseases. The goal …
Matched conditions: HISTIOCYTIC NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC